Wyeth, Progenics To Develop Methylnaltrexone Franchise
Companies plan to file NDAs for three formulations of the bowel dysfunction treatment over the next few years.
Companies plan to file NDAs for three formulations of the bowel dysfunction treatment over the next few years.